Sam Butler has been battling giant cell tumors since 2020 ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...

Passive income is the cash flow that arrives whether you are working, sleeping, or watching the market churn. For investors ...

As CAR T-cell therapy reaches community oncology, practice leaders discuss the challenges of payer hurdles, single case ...

Eli Lilly (LLY) acquires Ajax Therapeutics for $2.3B, adding AJ1-11095, a novel JAK2 inhibitor for myelofibrosis and blood ...

A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...

The discovery of a giant cell tumor in his cervical spine led Amsterdam baseball coach Robby Hisert to miss the 2025 season ...

After an 846-day cancer journey, Marriotts Ridge senior Abbi Livay celebrates ending treatment surrounded by her lacrosse ...

Eli Lilly (LLY) stock is in focus as the company agrees to buy cancer drug develoer Kelonia Therapeutics for up to $7B in cash. Read more here.

The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.

Tens of thousands of patients could benefit from a one-minute jab being rolled out on the NHS for more than a dozen cancers.